Statement Of Changes In Equity [Abstract]

GenSight Biologics S.A. - Filing #879715

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Increase (decrease) through appropriation of retained earnings, equity
34,015,000 EUR
EUR
34,015,000 EUR
EUR
30,868,000 EUR
30,868,000 EUR
Increase (decrease) through conversion of convertible instruments, equity
427,000 EUR
13,000 EUR
440,000 EUR
52,000 EUR
7,957,000 EUR
1,661,000 EUR
6,244,000 EUR
Share issue related cost
1,906,000 EUR
1,906,000 EUR
1,876,000 EUR
1,876,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.